LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 140 filers reported holding LEGEND BIOTECH CORP in Q1 2022. The put-call ratio across all filers is 1.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54,715,742 | -2.7% | 814,586 | 0.0% | 20.16% | +15.4% |
| Q2 2023 | $56,230,872 | -28.4% | 814,586 | -50.0% | 17.46% | -31.7% |
| Q1 2023 | $78,558,722 | +96494.9% | 1,629,173 | 0.0% | 25.55% | +8.0% |
| Q4 2022 | $81,328 | -99.9% | 1,629,173 | 0.0% | 23.66% | +21.0% |
| Q3 2022 | $66,470,000 | -25.8% | 1,629,173 | 0.0% | 19.56% | -14.5% |
| Q2 2022 | $89,605,000 | +51.3% | 1,629,173 | 0.0% | 22.89% | +104.5% |
| Q1 2022 | $59,204,000 | -22.0% | 1,629,173 | 0.0% | 11.19% | +29.5% |
| Q4 2021 | $75,936,000 | -7.8% | 1,629,173 | 0.0% | 8.64% | +19.6% |
| Q3 2021 | $82,371,000 | – | 1,629,173 | – | 7.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 814,586 | $56,230,872 | 17.46% |
| Paradigm Biocapital Advisors LP | 1,805,717 | $124,648,645 | 9.63% |
| HHLR ADVISORS, LTD. | 6,436,533 | $444,313,873 | 9.46% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,123,692 | $77,568,459 | 9.09% |
| RA Capital Management | 6,264,707 | $432,452,724 | 8.16% |
| Tri Locum Partners LP | 116,768 | $8,060,495 | 3.00% |
| Nicholas Investment Partners, LP | 593,167 | $40,946,318 | 2.80% |
| E Fund Management (Hong Kong) Co., Ltd. | 51,679 | $3,567 | 2.66% |
| Avidity Partners Management LP | 798,900 | $55,148,067 | 1.93% |
| Boxer Capital, LLC | 600,000 | $41,418 | 1.92% |